Primary Site >> Liver Cancer
Gene >> AKR1C2
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. PMID: 9973208 |
Ref: Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma. PMID: 12579257 |
Ref: Growth factor NUN increased AKR1C2 expression by activated CDK2 related RB signal transduction pathway in human liver cancer cell line. PMID: 15816479 |
Ref: Small interfering RNA (siRNA) inhibited human liver cancer cell line SMMC7721 proliferation and tumorigenesis. PMID: 18019706 Ref: AKR1C2 small interfering RNA (siRNA) inhibited beta-catenin expression and transcriptional activation in human liver cancer cell line QGY7701. PMID: 18251165 |
Ref: Bioequivalence studies of tibolone in premenopausal women and effects on expression of the tibolone-metabolizing enzyme AKR1C (aldo-keto reductase) family caused by estradiol. PMID: 18832293 |
Ref: AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer. PMID: 26351209 |
Ref: High-Content Functional Screening of AEG-1 and AKR1C2 for the Promotion of Metastasis in Liver Cancer. PMID: 26318406 |